Mayo Clinic Laboratories launches serology testing

Apr 20, 2020 | Jennifer O'Hara | @jenohara | Comments (2)


A new serology test from Mayo Clinic Laboratories is being used to identify the presence of immune response to SARS-CoV-2, the virus that causes COVID-19. The serology test is intended only to detect antibodies to the virus. It does not diagnose recent or active infection. Mayo Clinic Laboratories also offers a molecular test to diagnose very recent or active infection. Both tests are important tools in the pandemic response.

On the Mayo Clinic Q&A podcast, Dr. Elitza Theel, director of Mayo Clinic’s Infectious Diseases Serology Laboratory, explains why serology testing is initially focused on identifying people in areas where potential immunity is key, including front-line health care workers.

To practice safe social distancing during the COVID-19 pandemic, this interview was conducted using video conferencing. The sound and video quality are representative of the technology used.

Connect with others talking about testing and stay healthy in the COVID-19 support group.


Very excited to know that is happening, especially to support and protect our health care workers.


To all mayo research drs THANK
YOU! I do hope you discover how to put a stop to covid19!
My question is for us all with primary immune deficiency receiving ivigg
Are we covered by this infusion for this better then average people? Or are we higher risk? And does the ivigg prevalence contain any active virus of covid19 from the plasma donors? I have seen these plasma sites with drug users paid for blood! How does this risk effect us all?
These plasma sites ARE NOT TESTED FOR DISEASE AN THIS STUFF! How is it
Removed from plasma before we are given it??? Scarey getting this stuff!
If we get it from air particles or touch then what about these blood plasma donors?
Think about use rare humans with ivigg needs !

Please sign in or register to post a reply.